A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery — Stella

Home/Patient Preference/

View on ClinicalTrials.gov

Recruiting

Back to Patient Preference trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Ophthalmic Consultants of Long Island, Garden City, New York

Key details

Phase

Post-approval study

Sponsor

Ophthalmic Consultants of Long Island

Collaborators

Ocular Therapeutix, Inc.

Enrollment target

~50 participants

Started

November 2019

Primary completion

June 2020

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

22 Years – 100 Years

Last updated December 2019

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.